Coronary Artery Calcium Scans Offer Limited Added Value for Most Patients According to New Northwestern Medicine Research

Coronary artery calcium (CAC) scans have long been marketed as a definitive window into an individual’s cardiovascular future. By utilizing non-invasive CT imaging to detect calcified plaque within the arteries that supply blood to the heart, these scans provide a tangible score that many patients find reassuring or alarming. However, a significant new study published in the journal JAMA on August 26 suggests that the clinical utility of these scans is far more nuanced than previously understood, indicating that their benefit is largely restricted to a specific subset of the population.

For years, the medical community has grappled with how best to identify patients at risk of cardiovascular disease (CVD) before a life-altering event occurs. While the American Heart Association (AHA) has established standardized risk calculators—most recently the PREVENT (Predicting Risk of Cardiovascular Disease Events) equations—the integration of advanced imaging like the CAC scan has been a subject of ongoing debate. This latest research, led by scientists at the Northwestern University Feinberg School of Medicine, provides some of the most robust data to date on when these scans truly move the needle in clinical decision-making.

The Evolution of Risk Assessment: PREVENT vs. Imaging

To understand the weight of these findings, one must first understand the methodology behind cardiovascular risk prediction. The PREVENT equations represent the gold standard for clinical risk estimation. By aggregating widely available health metrics—including age, biological sex, blood pressure, cholesterol levels, and the presence of diabetes or kidney disease—physicians can calculate an individual’s 10-year or 30-year risk of developing cardiovascular disease.

Conversely, a CAC scan measures something entirely different: the physical manifestation of atherosclerosis. Atherosclerosis is the buildup of fats, cholesterol, and other substances in and on the artery walls. Over time, this plaque can calcify. A CAC scan quantifies this calcification, providing a score that correlates with the severity of the disease. In theory, if a risk calculator suggests a patient is at moderate risk, a high calcium score might provide the evidence needed to justify aggressive intervention, such as statin therapy.

However, the Northwestern study suggests that for a vast majority of the population, the PREVENT calculator is sufficient on its own. After tracking more than 6,000 adults between the ages of 45 and 79 for a decade, researchers found that the addition of a calcium score to the PREVENT equation resulted in only a marginal improvement in predictive accuracy. Specifically, the model’s ability to discriminate between those who would experience a cardiovascular event and those who would not—measured as a C-statistic—rose only from 0.73 to 0.75.

Study Methodology and Longitudinal Data

The research utilized data from the Multi-Ethnic Study of Atherosclerosis (MESA), a high-profile, longitudinal cohort study that has been instrumental in shaping modern cardiology guidelines. By evaluating a diverse group of over 6,000 participants, the Northwestern team was able to observe real-world outcomes over a 10-year period, during which approximately 6% of the study population experienced a major adverse cardiovascular event, such as a heart attack or stroke.

By comparing the predicted outcomes from the PREVENT calculator against the observed outcomes, and then layering in the CAC scores, the team determined that the overall clinical impact of the scans was modest. The data suggests that for patients at the extreme ends of the risk spectrum—either very low or very high—the scan provides little to no actionable information.

The "Borderline" Sweet Spot

The most significant finding of the study pertains to patients categorized by the PREVENT model as having "borderline" or "intermediate" risk. These individuals are often the most difficult to manage; their risk factors are not high enough to mandate immediate, aggressive intervention, but not low enough to ignore entirely.

For this specific group—defined in the study as those with a 3% to 9% estimated risk of a cardiovascular event within the next decade—the CAC scan proved to be a valuable tie-breaker. In these patients, the scan provided a clearer, more precise indication of who was truly at elevated risk and who was not. For a clinician, this is critical information. It can mean the difference between recommending lifestyle modifications alone or initiating a daily statin regimen.

The Risks of Over-Testing

Dr. Nilay Shah, the study’s senior author and an assistant professor of medicine in the division of cardiology at Northwestern University Feinberg School of Medicine, emphasized that the findings should serve as a cautionary note against the indiscriminate use of imaging.

"Routinely using a calcium scan in people who are at low risk may result in unnecessary radiation exposure, testing, and costs with unclear clinical benefits," Dr. Shah explained. Conversely, he noted that for high-risk patients, the scan is largely redundant. "Using calcium scans in people who are at high risk is likely to result in unnecessary testing because these individuals are recommended to start a statin regardless of what the calcium scan shows."

This underscores a fundamental principle of modern evidence-based medicine: the best test is not always the most expensive or the most technologically advanced; it is the test that provides the most utility for the specific patient in front of the clinician. Unnecessary testing not only strains the healthcare system financially but can also lead to "incidentalomas"—findings on a scan that are clinically insignificant but lead to further, often invasive, diagnostic procedures that carry their own risks.

Implications for Clinical Practice

The findings have immediate implications for how cardiologists and primary care physicians utilize screening tools. First, it validates the efficacy of the PREVENT calculator. Even without the inclusion of imaging, the model performed remarkably well, suggesting that clinicians can rely on these established equations for a significant portion of their patient base.

Second, it provides a clearer roadmap for the use of CAC scans. Rather than ordering scans for every patient concerned about their heart health, clinicians are encouraged to use them as a "second-tier" test for those in the middle of the risk distribution. This targeted approach could optimize patient care, reduce unnecessary healthcare spending, and ensure that those who are most likely to benefit from further diagnostic scrutiny receive it.

Future Directions and Research Gaps

Despite the clarity provided by this study, the research team acknowledged several limitations and areas for future inquiry. The current cohort, while diverse, focused on participants who were between 45 and 79 years old at the start of the study. Consequently, more research is needed to determine how these findings apply to younger adults.

Furthermore, Dr. Shah noted that certain populations, such as South Asian and Filipino adults, are underrepresented in current cardiovascular risk databases. Because these groups may have different risk profiles and physiological responses to atherosclerosis, it remains to be seen if the same predictive utility holds true across all ethnic and ancestral backgrounds.

As cardiovascular disease remains the leading cause of death in the United States, accounting for roughly 10% of the adult population between 30 and 79, the quest for precision medicine is more critical than ever. The study, supported by grants from the American Heart Association and the National Heart, Lung, and Blood Institute, highlights the ongoing need for refined diagnostic strategies that balance technological capabilities with the necessity of cost-effective, patient-centered care.

Summary of Key Findings

• Modest Overall Benefit: Adding coronary artery calcium scores to the PREVENT risk calculator yielded only a minor improvement in predictive accuracy for the general population.
• Utility in Mid-Range Risk: The scan is most effective for patients identified by standard models as having borderline or intermediate risk (3% to 9% 10-year risk).
• Avoiding Over-Diagnosis: Routine scanning of low-risk individuals and high-risk individuals is discouraged due to concerns over radiation, cost, and the lack of change in treatment pathways.
• Clinical Guidance: The study reinforces the importance of using established risk calculators as the primary tool for heart health assessment, with imaging reserved for specific clinical dilemmas.

As healthcare systems move toward more integrated and value-based care models, studies like this are essential for ensuring that innovation is guided by evidence. By moving away from a "one-size-fits-all" approach to diagnostic imaging, the medical community can better focus its resources on identifying and treating the patients who stand to benefit the most from intervention, ultimately reducing the burden of heart disease in the population.